Contribution of a Non Medicamentous Approach by Hypnosis on Quality of Life in Crohn Disease

• Status: Recruiting
• Trial end date: 2021-11-13
• Target enrollment: 0
• Participant gender: All

Summary

Evaluation of hypnosis therapy efficacy in addition to pharmacologic standard treatment of Croh disease during remission by the evaluation of quality of life;

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Grenoble

Criteria

Inclusion Criteria:

• patient with ileal or colic Crohn disease

• stable treatment for Crohn disease

• clinical and biologic remission (normal C reactive protein and fecal calprotectin < 100 µg/g)

• patient living in Grenoble area

• informed consent form

• social security affiliation

Exclusion Criteria:

• Person under legal protection (articles L1121-5 and L1121-8 of Public health code)

• Person in exclusion period of another study

• Hypnosis contraindication